News / Health

Measles Virus Proves Deadly Against Cancer

Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video.
Stacy Erholtz receives a test to confirm she's in remission from myeloma after receiving a novel virotherapy in this screenshot from a Mayo Clinic video.

Related Articles

Video Could Existing Drugs Be Used to Treat Deadly MERS Virus?

In lab studies, drugs against cancer, neurological disorders and other ailments show promise to help treat respiratory ailment

New Treatment Regenerates Muscle Lost in Traumatic Injury

Researchers say implanting material from a pig's bladder at the wound site enticed the patient's own stem cells to become muscle cells and regenerate tissue that had been lost
A new study has, for the first time, demonstrated that a specific kind of virotherapy can infect and kill cancer in humans, leaving healthy cells unharmed.
 
The study, conducted by the Mayo Clinic in Minnesota, involved just two patients, both of whom received a “single intravenous dose of an engineered measles virus (MV-NIS) that is selectively toxic to myeloma plasma cells," researchers said.
 
Multiple myeloma affects the plasma cells in the bone marrow and causes skeletal or soft tissue tumors. It is rarely cured.
 
The therapy brought about a complete remission in one of the patients, while only improving the second patient.
 
“This is the first study to establish the feasibility of systemic oncolytic virotherapy for disseminated cancer,” said Dr. Stephen Russell, a Mayo Clinic hematologist, and first author of the paper and co-developer of the therapy in a statement. “These patients were not responsive to other therapies and had experienced several recurrences of their disease.”
 
In an interview with VOA, Russell called viruses “the last untapped bioresource as destructive bioagents against cancer.”
 
The two patients in the trial were given enough measles virus to vaccinate 100 million people. In a video about the treatment, Mayo doctors say the modified measles virus makes cancer cells join together and “essentially explode.”
 
The therapy also may boost the patient’s immune system, allowing it to “mop up” any remaining cancer, they said.
 
Using re-engineered viruses to fight cancer, also known as oncolytic virotherapy, is nothing new, dating back to the 1950s, according to the Mayo Clinic. But, according to researches, this study provides the “first well documented case of a patient with disseminated cancer having a complete remission at all disease sites after virus administration.”
 
Good results with this kind of therapy have been seen with rodents, but this is the first time success has been reported in a human being. However, remission was only achieved in one of the two patients.

Mixed results for patients
 
The other patient did not respond as well. Nonetheless, by using a sophisticated imaging technique, doctors were able to tell that the virus had targeted cancerous cells.
 
Russell said he and his colleagues found the difference in reaction between the two patients “puzzling,” but had some theories about why.
 
He said the patient who’d gone into remission had less myeloma in her body and that the second patient’s cancer was in a “very advanced state” with “massive tumors in the legs and abdomen.”
 
Another theory was that the second patient had more tumors in the muscles.
 
“If we’d treated her earlier, we’d have done better, Russell said, adding that they might also have seen better results at a higher dose.
 
There were negative side effects, he said, such as severe flu-like symptoms almost immediately upon dosing. Despite that, one patient called the side effects “trivial,” compared to other treatments they’d received, according to Russell.
 
William Phelps, Director of the Preclinical and Translational Cancer Research Program at the American Cancer Society, said the study is exciting because it shows efficacy with humans.
 
“Viruses are very good at disseminating throughout the body,” he said, adding that they’re also adept at hunting, detecting and infecting metastatic tumors.
 
Another advantage of using viruses is that they’re mutable, said Phelps.
 
“We can make a lot of changes to change what cells they infect,” he said. “We can change their payloads to specifically kill cancer.”
 
According to an editorial accompanying the paper, Dr. John C. Bell of the Centre for Innovative Cancer Research in Ottawa, Canada, described the findings as a “benchmark to strive for and improve upon.”
 
When asked if the study had implications for other types of cancer, Russell answered with an emphatic yes.
 
“There’s no real reason why it can’t work on other cancers,” said Bell, adding that cancer provides the “perfect substrate” for viruses because they’re metabolically active, fast growing and, “don’t know how to turn off.
 
“Once the virus gets in there, it can just move,” he said. “There are a lot of reasons they’re happier growing in cancer.”
 
More trials are planned.
 
“We want to take this virus and test it much more efficiently in a larger group to determine how often it works,” said Russell.
 
According to the Mayo Clinic, more of the MV-NIS therapy is being manufactured for a larger, phase 2 clinical trial later this year.
 
Phelps said his one concern about the study was that the two patients did not have any antibodies for measles, making them very rare because most people have been vaccinated against or had the measles.
 
One possible next step is “trying to engineer the virus so that it wouldn’t be neutralized by your antibodies," said Phelps. “Intuitively, you should be able to do that."
 
Russell believes that what this study has proved is valuable and can be built upon.
 
“We recently have begun to think about the idea of a single shot cure for cancer, and that’s our goal with this therapy,” he said.

The findings appear in the peer-reviewed journal Mayo Clinic Proceedings.

Here's a video about the treatment:
 

You May Like

China May Be Biggest Winner From Ukraine Crisis

Missile sales, oil and gas shipments are among many areas that may drive Beijing and Moscow closer together in coming years More

Obama Faces Chaotic World, Limits of Power

Current foreign policy issues bring into focus challenges for US policymakers who are mindful of Americans' waning appetite for overseas military engagements More

SADC Meeting Lesotho Officials to Resolve Stalemate

Official says regional bloc has been engaged with leaders in Lesotho to resolve political disagreement that led to coup attempt More

This forum has been closed.
Comment Sorting
Comments
     
by: MOD from: china
May 18, 2014 8:21 AM
Hope it's useful and THX~!


by: Dr. Livkin from: UK
May 17, 2014 9:01 PM
However, there is POISON in the flu vaccine=MERCURY, a deadly neurotoxin that is NOT to be introduced into the human body unless of course, you want to invite cognitive disorders and cancer. FACTS AND RESEARCH WILL DICTATE THAT.


by: kanapathy pillai yogaraaj from: srilanka
May 17, 2014 5:05 AM
we support civilrights-Like


by: jom from: china
May 16, 2014 3:31 PM
Thank you for this hopeful article

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
West Africa Ebola Vaccine Trials Possible by Early 2015i
X
Carol Pearson
August 30, 2014 7:14 PM
A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video West Africa Ebola Vaccine Trials Possible by Early 2015

A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video Survivors Commemorate 70th Anniversary of Nazi Liquidation of Jewish Ghetto

When the German Nazi army occupied the Polish city of Lodz in 1939, it marked the beginning of a long nightmare for the Jewish community that once made up one third of the population. Roughly 200,000 people were forced into the Lodz Ghetto. Less than 7,000 survived. As VOA’s Kane Farabaugh reports, some survivors gathered at the Union League Club in Chicago on the 70th anniversary of the liquidation of the Lodz Ghetto to remember those who suffered at the hands of the Nazi regime.
Video

Video Cost to Raise Child in US Continues to Rise

The cost of raising a child in the United States continues to rise. In its latest annual report, the U.S. Department of Agriculture says middle income families with a child born in 2013 can expect to spend more than $240,000 before that child turns 18. And sending that child to college more than doubles that amount. VOA’s Deborah Block visited with a couple with one child in Alexandria, Virginia, to learn if the report reflects their lifestyle.
Video

Video Chaotic Afghan Vote Recount Threatens Nation’s Future

Afghanistan’s troubled presidential election continues to be rocked by turmoil as an audit of the ballots drags on. The U.N. says the recount will not be completed before September 10. Observers say repeated disputes and delays are threatening the orderly transfer of power and could have dangerous consequences. VOA correspondent Meredith Buel reports.
Video

Video Ukraine Battles Pro-Russia Rebel Assault

After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Growing Business Offers Paint with a Twist of Wine

Two New Orleans area women started a small business seven years ago with one thing in mind: to help their neighbors relieve the stress of coping with a hurricane's aftermath. Today their business, which pairs painting and a little bit of wine, has become one of the fastest growing franchises across the U.S. VOA’s June Soh met the entrepreneurs at their newest franchise location in the Washington suburbs.
Video

Video Ebola Vaccine Trials To Begin Next Week

The National Institutes of Health says it is launching early stage trials of a vaccine to prevent the Ebola virus, which has infected or killed thousands of people across West Africa. The World Health Organization says Ebola could infect more than 20,000 people across the region by the time the outbreak is over. The epidemic has health experts and governments scrambling to prevent more people from becoming infected. Zlatica Hoke has more.
Video

Video Asian Bacteria Threatens Florida Orange Trees

Florida's citrus fruit industry is facing a serious threat from a bacteria carried by the Asian insect called psyllid. The widespread infestation again highlights the danger of transferring non-native species to American soil. VOA’s George Putic reports.
Video

Video Aging Will Reduce Economic Growth Worldwide in Coming Decades

The world is getting older, fast. And as more people retire each year, fewer working-age people will be there to replace them. Bond rating agency Moody’s says that will lead to a decline in household savings; reducing global investments - which in turn, will lead to slower economic growth around the world. But experts say it’s not too late to mitigate the economic impact of the world’s aging populations. Mil Arcega has more.
Video

Video Is West Doing Enough to Tackle Islamic State?

U.S. President Barack Obama has ruled out sending ground troops to Iraq to fight militants of the so-called Islamic State, or ISIS, despite officials in Washington describing the extremist group as the biggest threat the United States has faced in years. Henry Ridgwell reports from London on the growing uncertainty over whether the West’s response to ISIS will be enough to defeat the terrorist threat.
Video

Video Coalition to Fight Islamic State Could Reward Assad

The United States along with European and Mideast allies are considering a broader assault against Islamic State fighters who have spread from Syria into Iraq and risk further destabilizing an already troubled region. But as VOA State Department Correspondent Scott Stearns reports, confronting those militants could end up helping the embattled Syrian President Bashar al-Assad.
Video

Video Made in America Socks Get Toehold in Online Fashion Market

Three young entrepreneurs are hoping to revolutionize the high-end sock industry by introducing all-American creations of their own. And they’re doing most of it the old-fashioned way. VOA’s Julie Taboh recently caught up with them to learn what goes into making their one-of-a-kind socks.
Video

Video Americans, Ex-Pats Send Relief Supplies to West Africa

Health organizations from around the world are sending supplies and specialists to the West African countries that are dealing with the worst Ebola outbreak in history. On a smaller scale, ordinary Americans and African expatriates living in the United States are doing the same. VOA's Carol Pearson reports.

AppleAndroid